UT14A_HUMAN - dbPTM
UT14A_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID UT14A_HUMAN
UniProt AC Q9BVJ6
Protein Name U3 small nucleolar RNA-associated protein 14 homolog A
Gene Name UTP14A
Organism Homo sapiens (Human).
Sequence Length 771
Subcellular Localization Nucleus, nucleolus .
Protein Description May be required for ribosome biogenesis..
Protein Sequence MTANRLAESLLALSQQEELADLPKDYLLSESEDEGDNDGERKHQKLLEAISSLDGKNRRKLAERSEASLKVSEFNVSSEGSGEKLVLADLLEPVKTSSSLATVKKQLSRVKSKKTVELPLNKEEIERIHREVAFNKTAQVLSKWDPVVLKNRQAEQLVFPLEKEEPAIAPIEHVLSGWKARTPLEQEIFNLLHKNKQPVTDPLLTPVEKASLRAMSLEEAKMRRAELQRARALQSYYEAKARREKKIKSKKYHKVVKKGKAKKALKEFEQLRKVNPAAALEELEKIEKARMMERMSLKHQNSGKWAKSKAIMAKYDLEARQAMQEQLSKNKELTQKLQVASESEEEEGGTEDVEELLVPDVVNEVQMNADGPNPWMLRSCTSDTKEAATQEDPEQLPELEAHGVSESEGEERPVAEEEILLREFEERRSLRKRSELSQDAEPAGSQETKDSGSQEVLSELRVLSQKLKENHQSRKQKASSEGTIPQVQREEPAPEEEEPLLLQRPERVQTLEELEELGKEECFQNKELPRPVLEGQQSERTPNNRPDAPKEKKKKEQMIDLQNLLTTQSPSVKSLAVPTIEELEDEEERNHRQMIKEAFAGDDVIRDFLKEKREAVEASKPKDVDLTLPGWGEWGGVGLKPSAKKRRRFLIKAPEGPPRKDKNLPNVIINEKRNIHAAAHQVRVLPYPFTHHWQFERTIQTPIGSTWNTQRAFQKLTTPKVVTKPGHIINPIKAEDVGYRSSSRSDLSVIQRNPKRITTRHKKQLKKCSVD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
9PhosphorylationTANRLAESLLALSQQ
CHHHHHHHHHHHHCH
24.0722199227
14PhosphorylationAESLLALSQQEELAD
HHHHHHHHCHHHHCC
24.9828102081
26PhosphorylationLADLPKDYLLSESED
HCCCCHHHCCCCCCC
18.7029255136
29PhosphorylationLPKDYLLSESEDEGD
CCHHHCCCCCCCCCC
36.1629255136
31PhosphorylationKDYLLSESEDEGDND
HHHCCCCCCCCCCCC
47.1529255136
45SumoylationDGERKHQKLLEAISS
CHHHHHHHHHHHHHC
55.55-
45SumoylationDGERKHQKLLEAISS
CHHHHHHHHHHHHHC
55.55-
51PhosphorylationQKLLEAISSLDGKNR
HHHHHHHHCCCCHHH
31.7130266825
52PhosphorylationKLLEAISSLDGKNRR
HHHHHHHCCCCHHHH
25.1130266825
56AcetylationAISSLDGKNRRKLAE
HHHCCCCHHHHHHHH
47.1226051181
65PhosphorylationRRKLAERSEASLKVS
HHHHHHHHHHHCEEE
29.0824719451
68PhosphorylationLAERSEASLKVSEFN
HHHHHHHHCEEEEEE
25.3524719451
72PhosphorylationSEASLKVSEFNVSSE
HHHHCEEEEEECCCC
34.5824732914
77PhosphorylationKVSEFNVSSEGSGEK
EEEEEECCCCCCCCE
24.6329255136
77UbiquitinationKVSEFNVSSEGSGEK
EEEEEECCCCCCCCE
24.6324816145
78PhosphorylationVSEFNVSSEGSGEKL
EEEEECCCCCCCCEE
41.5129255136
81PhosphorylationFNVSSEGSGEKLVLA
EECCCCCCCCEEEEH
39.4629255136
96PhosphorylationDLLEPVKTSSSLATV
HHCCCCCCCCHHHHH
33.7921712546
97PhosphorylationLLEPVKTSSSLATVK
HCCCCCCCCHHHHHH
16.5328674419
98PhosphorylationLEPVKTSSSLATVKK
CCCCCCCCHHHHHHH
34.3023312004
99PhosphorylationEPVKTSSSLATVKKQ
CCCCCCCHHHHHHHH
23.0725159151
102PhosphorylationKTSSSLATVKKQLSR
CCCCHHHHHHHHHHH
37.84-
122AcetylationTVELPLNKEEIERIH
EEECCCCHHHHHHHH
65.4926051181
122SumoylationTVELPLNKEEIERIH
EEECCCCHHHHHHHH
65.4928112733
127UbiquitinationLNKEEIERIHREVAF
CCHHHHHHHHHHHHH
35.3624816145
136MethylationHREVAFNKTAQVLSK
HHHHHHHHHHHHHHC
38.49115978867
141UbiquitinationFNKTAQVLSKWDPVV
HHHHHHHHHCCCCEE
2.6424816145
143UbiquitinationKTAQVLSKWDPVVLK
HHHHHHHCCCCEEEC
52.00-
155UbiquitinationVLKNRQAEQLVFPLE
EECCCCHHHEEECCC
35.7924816145
169UbiquitinationEKEEPAIAPIEHVLS
CCCCCCCCCHHHHHC
10.9224816145
179UbiquitinationEHVLSGWKARTPLEQ
HHHHCCCCCCCHHHH
31.3629967540
194UbiquitinationEIFNLLHKNKQPVTD
HHHHHHHCCCCCCCC
66.8533845483
196UbiquitinationFNLLHKNKQPVTDPL
HHHHHCCCCCCCCCC
61.86-
200PhosphorylationHKNKQPVTDPLLTPV
HCCCCCCCCCCCCHH
38.2825137130
205PhosphorylationPVTDPLLTPVEKASL
CCCCCCCCHHHHHHH
32.7325159151
211PhosphorylationLTPVEKASLRAMSLE
CCHHHHHHHHHCCHH
29.4721406692
216PhosphorylationKASLRAMSLEEAKMR
HHHHHHCCHHHHHHH
31.4821815630
221UbiquitinationAMSLEEAKMRRAELQ
HCCHHHHHHHHHHHH
35.9024816145
233UbiquitinationELQRARALQSYYEAK
HHHHHHHHHHHHHHH
2.6424816145
2402-HydroxyisobutyrylationLQSYYEAKARREKKI
HHHHHHHHHHHHHHH
30.41-
285AcetylationAALEELEKIEKARMM
HHHHHHHHHHHHHHH
69.6426051181
285UbiquitinationAALEELEKIEKARMM
HHHHHHHHHHHHHHH
69.6424816145
288UbiquitinationEELEKIEKARMMERM
HHHHHHHHHHHHHHH
44.78-
298MethylationMMERMSLKHQNSGKW
HHHHHCHHHCCCCHH
35.52-
305UbiquitinationKHQNSGKWAKSKAIM
HHCCCCHHHHHHHHH
16.6724816145
307MethylationQNSGKWAKSKAIMAK
CCCCHHHHHHHHHHH
51.91-
309MethylationSGKWAKSKAIMAKYD
CCHHHHHHHHHHHHC
41.02-
314SumoylationKSKAIMAKYDLEARQ
HHHHHHHHHCHHHHH
23.16-
314SumoylationKSKAIMAKYDLEARQ
HHHHHHHHHCHHHHH
23.16-
330UbiquitinationMQEQLSKNKELTQKL
HHHHHHHCHHHHHHH
39.3924816145
333UbiquitinationQLSKNKELTQKLQVA
HHHHCHHHHHHHHHH
7.0224816145
340UbiquitinationLTQKLQVASESEEEE
HHHHHHHHCCCHHHC
8.4624816145
341PhosphorylationTQKLQVASESEEEEG
HHHHHHHCCCHHHCC
42.6822210691
343PhosphorylationKLQVASESEEEEGGT
HHHHHCCCHHHCCCC
48.0626029660
389PhosphorylationSDTKEAATQEDPEQL
CCHHHHHHCCCHHHC
39.2728176443
397UbiquitinationQEDPEQLPELEAHGV
CCCHHHCHHHHHCCC
43.7724816145
405PhosphorylationELEAHGVSESEGEER
HHHHCCCCCCCCCCC
39.7429255136
407PhosphorylationEAHGVSESEGEERPV
HHCCCCCCCCCCCCC
43.3129255136
425UbiquitinationEILLREFEERRSLRK
HHHHHHHHHHHHHHH
45.9324816145
429PhosphorylationREFEERRSLRKRSEL
HHHHHHHHHHHHHHH
38.45-
433CitrullinationERRSLRKRSELSQDA
HHHHHHHHHHHCCCC
29.00-
433CitrullinationERRSLRKRSELSQDA
HHHHHHHHHHHCCCC
29.00-
434PhosphorylationRRSLRKRSELSQDAE
HHHHHHHHHHCCCCC
46.0223401153
437PhosphorylationLRKRSELSQDAEPAG
HHHHHHHCCCCCCCC
23.2029255136
445PhosphorylationQDAEPAGSQETKDSG
CCCCCCCCCCCCCCC
27.2729255136
448PhosphorylationEPAGSQETKDSGSQE
CCCCCCCCCCCCHHH
32.3022167270
449SumoylationPAGSQETKDSGSQEV
CCCCCCCCCCCHHHH
49.5028112733
449UbiquitinationPAGSQETKDSGSQEV
CCCCCCCCCCCHHHH
49.5024816145
451PhosphorylationGSQETKDSGSQEVLS
CCCCCCCCCHHHHHH
41.7322167270
453PhosphorylationQETKDSGSQEVLSEL
CCCCCCCHHHHHHHH
27.4129255136
458PhosphorylationSGSQEVLSELRVLSQ
CCHHHHHHHHHHHHH
39.5023927012
466AcetylationELRVLSQKLKENHQS
HHHHHHHHHHHHHHH
59.1425953088
477UbiquitinationNHQSRKQKASSEGTI
HHHHHHHHHHCCCCC
53.9524816145
479PhosphorylationQSRKQKASSEGTIPQ
HHHHHHHHCCCCCCC
35.6419691289
480PhosphorylationSRKQKASSEGTIPQV
HHHHHHHCCCCCCCC
44.9219691289
508UbiquitinationLLQRPERVQTLEELE
HHHCHHHHCCHHHHH
4.9324816145
510PhosphorylationQRPERVQTLEELEEL
HCHHHHCCHHHHHHH
33.0221815630
518UbiquitinationLEELEELGKEECFQN
HHHHHHHCHHHHHCC
38.3124816145
519AcetylationEELEELGKEECFQNK
HHHHHHCHHHHHCCC
64.0626051181
519SumoylationEELEELGKEECFQNK
HHHHHHCHHHHHCCC
64.0628112733
526AcetylationKEECFQNKELPRPVL
HHHHHCCCCCCCCCC
50.2526051181
538PhosphorylationPVLEGQQSERTPNNR
CCCCCCCCCCCCCCC
22.5925159151
541PhosphorylationEGQQSERTPNNRPDA
CCCCCCCCCCCCCCC
26.7325159151
566PhosphorylationIDLQNLLTTQSPSVK
HHHHHHHHCCCCCHH
26.4229255136
567PhosphorylationDLQNLLTTQSPSVKS
HHHHHHHCCCCCHHH
27.3329255136
569PhosphorylationQNLLTTQSPSVKSLA
HHHHHCCCCCHHHCC
19.6329255136
571PhosphorylationLLTTQSPSVKSLAVP
HHHCCCCCHHHCCCC
47.6429255136
574PhosphorylationTQSPSVKSLAVPTIE
CCCCCHHHCCCCCHH
21.2928555341
589CitrullinationELEDEEERNHRQMIK
HHCCHHHHHHHHHHH
47.75-
589CitrullinationELEDEEERNHRQMIK
HHCCHHHHHHHHHHH
47.75-
600UbiquitinationQMIKEAFAGDDVIRD
HHHHHHHCCCHHHHH
27.7933845483
610UbiquitinationDVIRDFLKEKREAVE
HHHHHHHHHHHHHHH
62.2724816145
620SumoylationREAVEASKPKDVDLT
HHHHHHCCCCCCCEE
64.23-
620SumoylationREAVEASKPKDVDLT
HHHHHHCCCCCCCEE
64.23-
627PhosphorylationKPKDVDLTLPGWGEW
CCCCCCEECCCCCCC
26.8328348404
640UbiquitinationEWGGVGLKPSAKKRR
CCCCCCCCCCHHHHC
30.88-
642PhosphorylationGGVGLKPSAKKRRRF
CCCCCCCCHHHHCEE
51.6522199227
652MethylationKRRRFLIKAPEGPPR
HHCEEEECCCCCCCC
61.10-
652UbiquitinationKRRRFLIKAPEGPPR
HHCEEEECCCCCCCC
61.1033845483
662UbiquitinationEGPPRKDKNLPNVII
CCCCCCCCCCCCEEE
64.5224816145
6722-HydroxyisobutyrylationPNVIINEKRNIHAAA
CCEEECCCCCHHHHH
46.38-
672UbiquitinationPNVIINEKRNIHAAA
CCEEECCCCCHHHHH
46.38-
701PhosphorylationQFERTIQTPIGSTWN
EEEEEECCCCCCCHH
17.0228857561
724AcetylationTTPKVVTKPGHIINP
CCCCCCCCCCCCCCC
37.0726051181
733SumoylationGHIINPIKAEDVGYR
CCCCCCCCHHHCCCC
47.16-
733AcetylationGHIINPIKAEDVGYR
CCCCCCCCHHHCCCC
47.1663796817
733SumoylationGHIINPIKAEDVGYR
CCCCCCCCHHHCCCC
47.1628112733
741PhosphorylationAEDVGYRSSSRSDLS
HHHCCCCCCCHHHCH
24.9625159151
742PhosphorylationEDVGYRSSSRSDLSV
HHCCCCCCCHHHCHH
22.2925159151
743PhosphorylationDVGYRSSSRSDLSVI
HCCCCCCCHHHCHHH
36.7325159151
745PhosphorylationGYRSSSRSDLSVIQR
CCCCCCHHHCHHHHC
44.8723186163
748PhosphorylationSSSRSDLSVIQRNPK
CCCHHHCHHHHCCCC
23.3619691289

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of UT14A_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of UT14A_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of UT14A_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NINL_HUMANNINLphysical
16189514
CEP70_HUMANCEP70physical
16189514
LDOC1_HUMANLDOC1physical
16189514
CC85B_HUMANCCDC85Bphysical
16189514
HOOK2_HUMANHOOK2physical
16189514
P53_HUMANTP53physical
21078665
GA45G_HUMANGADD45Gphysical
15383276
WDR18_HUMANWDR18physical
22939629
VDAC2_HUMANVDAC2physical
22939629
SMYD1_HUMANSMYD1physical
23455924
DKC1_HUMANDKC1physical
26344197
NOP56_HUMANNOP56physical
26344197
NOP58_HUMANNOP58physical
26344197
RPF2_HUMANRPF2physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of UT14A_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29; SER-31; SER-437 ANDSER-445, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-26; SER-29; SER-31;SER-77; SER-437 AND SER-445, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29; SER-31; SER-52;SER-77; SER-405; SER-407 AND SER-445, AND MASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; SER-99; THR-389;SER-405; SER-407; SER-437; SER-445; SER-453; SER-479; THR-541;SER-569; SER-571 AND SER-748, AND MASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-437; SER-445 ANDSER-453, AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434, AND MASSSPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29 AND SER-451, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29; SER-31 AND SER-445,AND MASS SPECTROMETRY.

TOP